. Author manuscript; available in PMC: 2023 Jan 12.

Published in final edited form as: J Vasc Interv Radiol. 2022 Sep 6;33(12):1578–1587.e5. doi: 10.1016/j.jvir.2022.08.027

Table 3.

Tumor Dose and Nontumor Liver Dose

Variable	Mean TD (Gy)	Paired t test with Rx⁹⁰Y (P value)	Correlation with Rx⁹⁰Y (r)	P value	Mean NTLD (Gy)	Paired t test with Rx⁹⁰Y (P value)	Correlation with Rx⁹⁰Y (r)	P value
Entire cohort: MAA	474	.68	0.74	<.001	117	.003	0.93	<.001
Entire cohort: Scout⁹⁰Y	470	.44	0.9	<.001	91	.163	0.97	<.001
Entire cohort: Rx⁹⁰Y	491				87
Nonsegmental: MAA	396	.83	0.341	.232	67	.14	0.44	.114
Nonsegmental: Scout⁹⁰Y	404	.75	0.93	<.001	62	.19	0.95	<.001
Nonsegmental: Rx⁹⁰Y	412				61
Segmental: MAA	534	.71	0.87	<.001	164	.005	0.92	<.001
Segmental: Scout⁹⁰Y	521	.49	0.91	<.001	117	.23	0.97	<.001
Segmental: Rx⁹⁰Y	552				110

⁹⁰Y = yttrium-90; MAA = macroaggregated albumin; NTLD = nontumor liver dose; Rx⁹⁰Y = therapeutic yttrium-90; TD = tumor dose. Statistically significant values are set in bold.